Latest Financial Performance News

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.

Amotiv Limited reports a slight decline in EBITA for FY25 alongside a significant non-cash impairment on its APG business, reflecting a cautious outlook amid challenging market conditions.

Bod Science reports a solid net cash inflow of $858,000 in Q4 FY2025, driven by R&D incentives and Biortica funding, while awaiting shareholder approval to complete a key acquisition.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.

Credit Clear Limited has outperformed its FY25 financial guidance with a 76% rise in underlying EBITDA and secured exclusive digital debt recovery contracts with leading insurers, setting a robust stage for FY26 growth.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

PPK Group’s majority-owned PowerPlus Energy launches two Clean Energy Council-approved batteries eligible for the Australian Government’s new Cheaper Home Batteries Program rebates, positioning itself to capture a significant share of the emerging residential energy storage market.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Amaero Ltd reports solid June quarter revenue and signs a pivotal five-year exclusive supply agreement with Velo3D, underpinning its growth outlook and updated EBITDA guidance for FY2027.

BKI Investment Company posted a solid financial performance for FY2025 with a 1% increase in dividends and introduced a neutralised Dividend Reinvestment Plan to maintain capital neutrality. Despite modest portfolio underperformance against major ETFs, BKI continues to offer an attractive dividend yield amid shifting market dynamics.

BKI Investment Company Limited reported a modest rise in revenue and operating profit for FY2025, alongside a 1% increase in dividends, supported by robust returns from key portfolio holdings.